Serum chemokine IL-8 acts as a biomarker for identifying COVID-19-associated persistent severe acute kidney injury

Serum chemokine IL-8 acts as a biomarker for identifying COVID-19-associated persistent severe acute kidney injury

AbstractObjectives Persistent severe acute kidney injury (PS-AKI) is associated with poor clinical outcomes. Our study attempted to evaluate the diagnostic value of chemokines for early-stage PS-AKI prediction.Methods According to the KDIGO criteria, 115 COVID-19 patients diagnosed with stage 2/3 AK...

Full description

Bibliographic Details
Main Authors: Zhi He, Jing-jing Liu, Shao-lei Ma
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Renal Failure
Subjects:
covid-19
acute kidney injury
IL-8
IP-10
biomarker
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2311316

Internet

https://www.tandfonline.com/doi/10.1080/0886022X.2024.2311316

Similar Items